PL374402A1 - Method for the protection of endothelial and epithelial cells during chemotherapy - Google Patents
Method for the protection of endothelial and epithelial cells during chemotherapyInfo
- Publication number
- PL374402A1 PL374402A1 PL03374402A PL37440203A PL374402A1 PL 374402 A1 PL374402 A1 PL 374402A1 PL 03374402 A PL03374402 A PL 03374402A PL 37440203 A PL37440203 A PL 37440203A PL 374402 A1 PL374402 A1 PL 374402A1
- Authority
- PL
- Poland
- Prior art keywords
- endothelial
- protection
- epithelial cells
- cells during
- during chemotherapy
- Prior art date
Links
- 238000002512 chemotherapy Methods 0.000 title 1
- 210000002889 endothelial cell Anatomy 0.000 title 1
- 230000003511 endothelial effect Effects 0.000 title 1
- 210000002919 epithelial cell Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38411402P | 2002-05-31 | 2002-05-31 | |
| US38743802P | 2002-06-11 | 2002-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374402A1 true PL374402A1 (en) | 2005-10-17 |
Family
ID=29715309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374402A PL374402A1 (en) | 2002-05-31 | 2003-06-02 | Method for the protection of endothelial and epithelial cells during chemotherapy |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1509235A1 (xx) |
| JP (1) | JP2005527636A (xx) |
| CN (1) | CN1304011C (xx) |
| AU (1) | AU2003238189A1 (xx) |
| CA (1) | CA2487171A1 (xx) |
| EA (1) | EA008213B1 (xx) |
| HR (1) | HRP20041213A2 (xx) |
| IL (1) | IL165353A0 (xx) |
| IS (1) | IS7548A (xx) |
| MX (1) | MXPA04011941A (xx) |
| NO (1) | NO20045655L (xx) |
| NZ (1) | NZ536864A (xx) |
| PL (1) | PL374402A1 (xx) |
| RS (1) | RS102504A (xx) |
| UA (1) | UA83628C2 (xx) |
| WO (1) | WO2003101468A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20031714A1 (it) * | 2003-09-05 | 2005-03-06 | Gentium Spa | Formazioni ad azione antitumorale. |
| JP6069209B2 (ja) * | 2010-11-12 | 2017-02-01 | ジェンティウム ソシエタ ア レスポンサビリタ リミタータ | 移植片対宿主病（ｇｖｈｄ）の予防および／または治療に使用するためのデフィブロタイド |
| CN104619857A (zh) | 2012-06-22 | 2015-05-13 | 真蒂奥姆有限公司 | 用于测定去纤维蛋白多核苷酸的生物活性的基于优球蛋白的方法 |
| EP3026122A1 (en) * | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Cellular-based method for determining the potency of defibrotide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998048843A1 (en) * | 1997-04-28 | 1998-11-05 | Arsinur Burcoglu | Method of treating hiv infection and related secondary infections thereof |
-
2003
- 2003-06-02 CN CNB038125013A patent/CN1304011C/zh not_active Expired - Fee Related
- 2003-06-02 RS YU102504A patent/RS102504A/sr unknown
- 2003-06-02 PL PL03374402A patent/PL374402A1/xx not_active Application Discontinuation
- 2003-06-02 UA UA20041109654A patent/UA83628C2/ru unknown
- 2003-06-02 EA EA200401448A patent/EA008213B1/ru not_active IP Right Cessation
- 2003-06-02 WO PCT/EP2003/005753 patent/WO2003101468A1/en active Application Filing
- 2003-06-02 EP EP03735516A patent/EP1509235A1/en not_active Withdrawn
- 2003-06-02 JP JP2004508823A patent/JP2005527636A/ja active Pending
- 2003-06-02 MX MXPA04011941A patent/MXPA04011941A/es unknown
- 2003-06-02 CA CA002487171A patent/CA2487171A1/en not_active Abandoned
- 2003-06-02 NZ NZ536864A patent/NZ536864A/en unknown
- 2003-06-02 AU AU2003238189A patent/AU2003238189A1/en not_active Abandoned
-
2004
- 2004-11-23 IL IL16535304A patent/IL165353A0/xx unknown
- 2004-11-24 IS IS7548A patent/IS7548A/is unknown
- 2004-12-27 HR HR20041213A patent/HRP20041213A2/xx not_active Application Discontinuation
- 2004-12-27 NO NO20045655A patent/NO20045655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20045655L (no) | 2004-12-27 |
| UA83628C2 (ru) | 2008-08-11 |
| JP2005527636A (ja) | 2005-09-15 |
| HRP20041213A2 (en) | 2006-04-30 |
| EA200401448A1 (ru) | 2005-06-30 |
| WO2003101468A1 (en) | 2003-12-11 |
| MXPA04011941A (es) | 2005-07-26 |
| EA008213B1 (ru) | 2007-04-27 |
| CA2487171A1 (en) | 2003-12-11 |
| IS7548A (is) | 2004-11-24 |
| EP1509235A1 (en) | 2005-03-02 |
| RS102504A (xx) | 2006-12-15 |
| NZ536864A (en) | 2008-08-29 |
| IL165353A0 (en) | 2006-01-15 |
| CN1655801A (zh) | 2005-08-17 |
| CN1304011C (zh) | 2007-03-14 |
| AU2003238189A1 (en) | 2003-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003232890A8 (en) | Metal air cell system | |
| HK1135322A1 (en) | Anti-aging agent | |
| GB0212825D0 (en) | Methods compositions and kits for cell separation | |
| AU2003241609A1 (en) | Methods and articles for reducing airborne particulates | |
| AU2003268033A8 (en) | Systems and methods for cell preservation | |
| AU2003241313A8 (en) | Compositions and methods for stem cell delivery | |
| EP1546361A4 (en) | AUTOSTIMULATING CELLS AND PROCESS FOR THEIR PRODUCTION AND USE | |
| EP1546301A4 (en) | DEVICE AND METHODS FOR ISOLATING TARGET CELLS | |
| AU2002326949A1 (en) | Method for the inhibition of methanogenesis | |
| AU2003241392A1 (en) | Package with pocket and method for making the same | |
| IL163845A0 (en) | Method and system for the automaticplanning of experiments | |
| EP1506537A4 (en) | TALKING E-BOOK | |
| AU2003301498A8 (en) | Thin films and methods for forming thin films utilizing ecae-targets | |
| PL375545A1 (en) | Weldable steel building component and method for making same | |
| EP1506778A4 (en) | INHIBITORS OF TGF- $ G (A) EXPRESSION | |
| AU2003222058A1 (en) | Materials and methods for inhibiting wip-1 | |
| IL165353A0 (en) | Method for the protection of endothelial and epithelial cells during chemotherapy | |
| AU2003292720A8 (en) | Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same | |
| AU2003295574A1 (en) | Method and compositions for temporarily incapaciting subjets | |
| EP1575512A4 (en) | METHOD AND COMPOSITIONS FOR THE EPITHELIAL CELL DIFFERENTIATION IN THE PROSTATE | |
| EP1575512A3 (en) | Methods and compositions for prostate epithelial cell differentiation | |
| GB2394878B (en) | Hooklink and lead discharge system | |
| AU2003269543A1 (en) | Block fabrication method and construction method | |
| AU2003287550A1 (en) | Corrosion protection for metals in cementitious material and method of applying and making the same | |
| AU2003275240A8 (en) | Methods and compositions for soluble cpg15 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |